News + Filings Transactions Holdings
|
Third Rock Ventures II, L.P.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/15/2021 | Jounce Therapeutics, Inc. | JNCE | Other (disposition) | Common Stock | 1.8M | $0.00 | $0 | | 09/15/2021 |
06/10/2021 | Jounce Therapeutics, Inc. | JNCE | Other (disposition) | Common Stock | 1.5M | $0.00 | $0 | | 06/10/2021 |
06/04/2021 | Revolution Medicines, Inc. | RVMD | Sale | Common Stock | 165k | $30.23 | $5M | | 06/03/2021 |
06/03/2021 | Revolution Medicines, Inc. | RVMD | Sale | Common Stock | 378.1k | $30.20 | $11.4M | | 06/03/2021 |
05/26/2021 | Revolution Medicines, Inc. | RVMD | Sale | Common Stock | 1.2M | $30.53 | $37.6M | | 05/25/2021 |
05/25/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 552.5k | $8.00 | $4.4M | | 05/25/2021 |
05/25/2021 | Revolution Medicines, Inc. | RVMD | Sale | Common Stock | 135k | $30.93 | $4.2M | | 05/25/2021 |
03/11/2021 | Jounce Therapeutics, Inc. | JNCE | Other (disposition) | Common Stock | 1.2M | $0.00 | $0 | | 03/11/2021 |
03/01/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 1.4M | $11.75 | $17M | | 03/01/2021 |
11/19/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 15k | $7.01 | $105.1k | | 11/19/2020 |
11/17/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 15k | $7.25 | $108.8k | | 11/17/2020 |
11/11/2020 | Jounce Therapeutics, Inc. | JNCE | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | | 11/11/2020 |
03/07/2018 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | | 03/07/2018 |
12/06/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | | 12/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Conversion | Common Stock | 2.6M | $0.00 | $0 | | 11/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Purchase | Common Stock | 215k | $14.00 | $3M | | 11/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Conversion | Series A Preferred Stock | 6.1M | $0.00 | $0 | | 11/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Conversion | Series B Preferred Stock | 4.6M | $0.00 | $0 | | 11/06/2017 |
09/28/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | | 09/28/2017 |
09/28/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | | 09/28/2017 |
09/26/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 400k | $43.00 | $17.2M | | 09/25/2017 |
09/25/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 201.4k | $43.00 | $8.7M | | 09/25/2017 |
09/11/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 20k | $44.25 | $885.1k | | 09/08/2017 |
09/08/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 900 | $42.39 | $38.1k | | 09/08/2017 |
09/08/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 200.4k | $41.00 | $8.2M | | 09/08/2017 |
06/14/2017 | Global Blood Therapeutics, Inc. | GBT | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | | 06/14/2017 |
04/06/2017 | Global Blood Therapeutics, Inc. | GBT | Other (disposition) | Common Stock | 2M | $0.00 | $0 | | 04/06/2017 |
03/30/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 850k | $0.00 | $0 | | 03/30/2017 |
12/14/2016 | Global Blood Therapeutics, Inc. | GBT | Other (disposition) | Common Stock | 2M | $0.00 | $0 | | 12/14/2016 |
11/29/2016 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 850k | $0.00 | $0 | | 11/29/2016 |
08/19/2016 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | | 08/19/2016 |
05/16/2016 | Sage Therapeutics, Inc. | SAGE | Sale | Common Stock | 850k | $31.25 | $26.6M | | 05/16/2016 |
11/12/2015 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 1.7M | $0.00 | $0 | | 11/12/2015 |
11/12/2015 | Sage Therapeutics, Inc. | SAGE | Other (acquisition) | Common Stock | 109.8k | $0.00 | $0 | | 11/12/2015 |
11/12/2015 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 109.8k | $0.00 | $0 | | 11/12/2015 |
|
|